Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
22 May 2018Website:
http://www.exicuretx.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 20:57:56 GMTDividend
Analysts recommendations
Institutional Ownership
XCUR Latest News
Exicure (NASDAQ: XCUR ) stock is rising higher on Friday despite a lack of news from the early-stage biotechnology company. Exicure hasn't released any recent press releases or made any filings that would result in today's stock rally.
What type of business is Exicure?
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
What sector is Exicure in?
Exicure is in the Healthcare sector
What industry is Exicure in?
Exicure is in the Biotechnology industry
What country is Exicure from?
Exicure is headquartered in United States
When did Exicure go public?
Exicure initial public offering (IPO) was on 22 May 2018
What is Exicure website?
https://www.exicuretx.com
Is Exicure in the S&P 500?
No, Exicure is not included in the S&P 500 index
Is Exicure in the NASDAQ 100?
No, Exicure is not included in the NASDAQ 100 index
Is Exicure in the Dow Jones?
No, Exicure is not included in the Dow Jones index
When does Exicure report earnings?
The next expected earnings date for Exicure is 09 August 2024